Hematris Overview

  • Founded
  • 2006
  • Status
  • Out of Business
  • Latest Deal Type
  • Liquidation

Hematris General Information


Developer of hemostasis products designed to help in earlier mobilization of the patient. The company's hemostasis products are absorbent dressing containing substances that is used on external wounds to stop severe arterial or venous bleeding immediately, enabling patients to prevent secondary bleeding.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Devices and Supplies
Primary Office
  • Professor-Messerschmitt-Street 3
  • 85579 Neubiberg
  • Germany
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hematris Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Bankruptcy: Liquidation 14-Mar-2017 00.000 Completed Bankruptcy: Liquidation
2. Early Stage VC 30-Nov-2009 00.000 00.000 Completed Startup
1. Early Stage VC 01-Jan-2006 Completed Startup
To view Hematris’s complete valuation and funding history, request access »

Hematris Executive Team (1)

Name Title Board Seat Contact Info
Stefan Bertsch Chief Executive Officer & Managing Director
To view Hematris’s complete executive team members history, request access »